Cellular responses to Loa loa experimental infection in mandrills (Mandrillus sphinx) vaccinated with irradiated infective larvae.
In order to shed light on the mechanisms of antifilarial protective immunity, we investigated the course of experimental loaiosis after vaccination in a nonhuman primate host, Mandrillus sphinx. Six vaccinated (V) mandrills received 50 irradiated L3 while six nonvaccinated (NV) received saline solution on days -60, -30 and -15. All animals were challenged with 100 intact L3 (day 0). Parasitological and immunological status were followed for 9 months. Vaccination delayed the appearance and mean peak of microfilaraemia. Five mandrills (Mf-) were never microfilaraemic (one V mandrill) or microfilaraemic on only one occasion (2 V and 2 NV), the other seven having stable microfilaraemia (Mf+). The cytokine response of peripheral blood mononuclear cells to L3 (L3 Ag) was Th2 dominated, while microfilariae (Mf Ag) elicited a Th0-like response. During vaccination, Th2 cytokine production significantly increased in V mandrills against L3 Ag, as well as Mf Ag, whereas Th1 cytokines decreased. On day 60 postinoculation, cellular proliferation was higher in V mandrills in response to L3 and Mf Ags and PHA-L mitogen. At the end of prepatency (on day 130), mandrills with delayed appearance of microfilaraemia exhibited a high, transient IL-2 and IL-4 secretion in response to L3 Ag. Finally, high anti-Mf Th2 cytokine levels characterized Mf-mandrills not only during prepatency, but also (for IL-5) before immunization. However, the presence of a balanced Th1 anti-L3 response during prepatency in the amicrofilaraemic mandrill suggests its importance in protective immunity. Taken together, our data suggest that Th2 cells and also Th1 components of the antifilarial response, especially to larval antigen, may contribute to parasite elimination.
Ungeheuer
M
M
Centre International de Recherches Médicales de Franceville, Franceville, Gabon.
Elissa
N
N
Morelli
A
A
Georges
A J
AJ
Deloron
P
P
Debre
P
P
Bain
O
O
Millet
P
P
D000818:Animals; D000947:Antigens, Helminth / Q000008:administration & dosage; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D007814:Larva / Q000276:immunology; D008117:Loa / Q000276:immunology*; D008118:Loiasis / Q000276:immunology* / Q000469:parasitology / Q000517:prevention & control*; D008213:Lymphocyte Activation; D008297:Male; D008842:Microfilariae / Q000276:immunology; D010215:Papio; D018512:Parasitemia / Q000276:immunology / Q000469:parasitology / Q000517:prevention & control; D018417:Th1 Cells / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology; D014611:Vaccination
D000947:Antigens, Helminth